Delia Rota-Scalabrini

4PUBLICATIONS
47CO-AUTHORS
Radiation therapyMedical mycologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 25, 2026
RENOIR phase 3 rituximab-lenalidomide vs rituximab as maintenance treatment in relapsed/refractory follicular lymphoma.

|Dec 04, 2023
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma.

Mattia D'Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini

|Jun 06, 2022
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma.

Luca Bertamini, Stefania Oliva, Delia Rota-Scalabrini

|Oct 01, 2021
Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial.

Umberto Ricardi, Mario Levis, Andrea Evangelista

Pageof 1

Frequent Collaborators

2 joint publications

Pellegrino Musto

2 joint publications

Francesca Gay

2 joint publications

Renato Zambello

2 joint publications

Paolo Corradini